MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,669,421 | -36.9% | 18,300 | 0.0% | 0.90% | -30.1% |
| Q2 2023 | $4,227,300 | +1114.7% | 18,300 | +242.1% | 1.29% | +1049.1% |
| Q3 2022 | $348,000 | -93.5% | 5,350 | +1296.9% | 0.11% | +100.0% |
| Q2 2022 | $5,350,000 | +5.6% | 383 | -92.8% | 0.06% | -95.1% |
| Q1 2022 | $5,066,000 | +208.7% | 5,350 | -46.5% | 1.14% | +46.4% |
| Q3 2018 | $1,641,000 | -41.2% | 10,000 | 0.0% | 0.78% | -27.2% |
| Q2 2018 | $2,790,000 | +21.7% | 10,000 | -60.0% | 1.07% | +32.5% |
| Q4 2017 | $2,293,000 | – | 25,000 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |